# WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer

> **NCT01144442** · NA · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 10 (actual)

## Conditions studied

- Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Carcinoma

## Interventions

- **DRUG:** Hyperthermic intraperitoneal chemotherapy with Carboplatin
- **OTHER:** Isotonic saline (perfusate)
- **PROCEDURE:** Surgery
- **DRUG:** Carboplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT01144442
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07-27
- **Primary completion:** 2013-09-25
- **Final completion:** 2015-05-01
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** PI Request
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01144442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01144442, "WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01144442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*